1.8499
-0.0501 (-2.64%)
-0.0501 (-2.64%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.58
High
4.26
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.0501 | -2.64% | 1.8499 | 19:17:43 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.90 | 1.75 | 1.90 | 1.82 | 1.90 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.80 | 1.85 | 0.05 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,824 | 923,733 | $ 1.80 | $ 1,661,968 | 861,882 | 0.58 - 4.26 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:44:46 | 70 | $ 1.80 | USD |
Outlook Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 235.28M | 127.18M | 105.54M | $ 8.15M | $ - | -0.99 | -1.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Outlook Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.22 | 2.25 | 1.75 | 1.96 | 1,147,205 | -0.3701 | -16.67% |
| 1 Month | 2.30 | 2.52 | 1.75 | 2.19 | 1,025,321 | -0.4501 | -19.57% |
| 3 Months | 1.31 | 4.26 | 0.9285 | 2.24 | 5,072,881 | 0.5399 | 41.21% |
| 6 Months | 0.8602 | 4.26 | 0.69 | 2.06 | 2,788,680 | 0.9897 | 115.05% |
| 1 Year | 0.76 | 4.26 | 0.58 | 1.63 | 2,583,844 | 1.09 | 143.41% |
| 3 Years | 5.60 | 20.00 | 0.4011 | 1.89 | 1,877,552 | -3.75 | -66.97% |
| 5 Years | 5.60 | 20.00 | 0.4011 | 1.89 | 1,877,552 | -3.75 | -66.97% |
Outlook Therapeutics Description
| Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |
